View Document Preview and Link Document Date: 2012-08-09 06:01:03 Open Document File Size: 472,38 KB Share Result on Facebook
City Nurnberg / Oltersdorf / Munich / Heidelberg / St. Louis / Santa Cruz / Del Principe / Birmingham / Victoria / Grenzach-Wyhlen / Queudeville / Sulzfeld / / Company Armstrong SA / Deiss LP / Sigma-Aldrich / Amersham / SPSS / IBM / IgG / AMP / Quest software / GE / Shurtleff SA / Irvine AE / Fresenius / Kohler / Creative Commons / Macmillan Publishers Limited / / Country Canada / Germany / United States / / Currency pence / / / Event Product Issues / Man-Made Disaster / / Facility Ulm University / University Medical Center Ulm / University of Ulm / Roswell Park Memorial Institute / / / IndustryTerm risk / Treatment of acute lymphoblastic leukemia / distal signaling machinery / apoptosis machinery / treatment of recurrent childhood acute lymphoblastic leukemia / / MedicalCondition TTLshort leukemia / B-lineage acute lymphoblastic leukemia / adult acute myeloid leukemia / JE / individual NOD/SCID / xenograft leukemia / c-ALL / common acute lymphoblastic leukemia / ALL leukemia / overt leukemia / CRAC-negative leukemia / pro-B ALL / CRAC-positive leukemia / late leukemia onset / Long Short CRAC Positive Negative NOD/SCID / apoptosis deficiency / unique leukemia / Disease Apoptosis deficiency / NOD/ SCID / TTLlong/favorable outcome leukemia / leukemia / TTLlong phenotype leukemias / apoptosis resistant leukemia / Cancer / c-ALL pre-B ALL / prolonged leukemia / highly resistant leukemia / acute lymphoblastic leukemia / deficiency / acute myeloid leukemia / prolonged NOD/SCID engraftment / TTLshort leukemias / myeloid cell leukemia / rapid leukemia / high leukemia / mixed lineage leukemia / acute myeloid leukaemia / pediatric acute lymphoblastic leukemia / metastasis / vivo tumor / CRAC-positive leukemias / individual leukemia / human cancers / Rapid NOD/SCID / TTLshort/early-relapse leukemia / previously established xenograft leukemias / infant acute lymphoblastic leukemia / lineage leukemia / leukemias / MS / NOD/SCID / CRAC-negative leukemias / human leukemia / Disease / acute leukemia / novo acute myeloid leukemia / myeloid leukemias / immune-deficient SCID / myeloid leukemia / human acute lymphoblastic leukemia / TTLlong leukemia / primary leukemia / prolonged NOD/SCID / P et al. Childhood ALL / patient leukemia / acute lymphoblastic leukaemia / TTLshort leukemia samples / SCID / molecular minimal residual disease / each leukemia / human disease / / MedicalTreatment radiotherapy / remission induction / chemotherapy / / NaturalFeature Charles River / / Organization Wilhelm Sander Foundation / German Research Foundation / European Hematology Association / University of Ulm / Department of Pediatrics and Adolescent Medicine / Foundation for Leukemia Research / Roswell Park Memorial Institute / Graduate School / Ulm University / / Person Susann Baumgart / Manuel Hermann / Shi Apoptosis / Simone Miller / / / Position Prime Minister / forward / Germany *Corresponding author / / Product FS / prednisone / penicillin / adenosine / beta-2 / apoptosis signaling / downstream apoptosis signaling / apoptosis / / ProvinceOrState British Columbia / Victoria / / Technology apoptosis / gene expression / chemotherapy / gel electrophoresis / alpha / antibodies / Biotechnology / transplantation / Image Processing / performed using the following antibodies / / URL www.nature.com/cddis / http / SocialTag 
Rapid engraftment of human ALL in NOD/SCID mice involves deficient apoptosis signaling